tiprankstipranks
Burcon Nutrascience (BRCNF)
OTHER OTC:BRCNF
US Market

Burcon Nutrascience (BRCNF) Earnings Dates, Call Summary & Reports

67 Followers

Earnings Data

Report Date
Aug 17, 2026
TBA (Confirmed)
Period Ending
2027 (Q1)
Consensus EPS Forecast
-0.05
Last Year’s EPS
-0.19
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2026
Earnings Call Date:Jun 24, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong operational progress and accelerating commercial traction — material revenue growth (nearly sixfold YoY), expanding customer pipeline (200+ projects and 30+ active buyers), repeat orders, and significant production improvements (60% higher daily production). Management also demonstrated cost discipline (G&A -23%, R&D -65%) and secured partial financing with partner and insider support. Primary challenges are the small absolute revenue base ($2.3M), remaining facility capital work and capacity planning, lengthy customer adoption cycles (9–18 months), and ongoing liquidity/financing considerations. Overall, the positive operational momentum and validated customer demand outweigh the early-stage risks and financing needs, but execution against scaling and profitability targets remains critical.
Company Guidance
Management guided to achieve $10 million in sales in calendar 2026 and reach positive operating cash flow, forecasting significant quarter‑over‑quarter revenue growth into fiscal 2027 with fiscal Q1 expected to grow about 50% versus the prior quarter. They pointed to FY2026 operational results of $2.3 million revenue (nearly sixfold year‑over‑year), double‑digit QoQ growth in Q3 and Q4, a 60% higher daily production record versus the previous quarter, more than 200 active projects, 30+ active buyers, and three new product launches, alongside cost discipline (G&A down 23% and R&D down 65%). They also noted a $6.9 million convertible note financing (with $4.0 million closed in FY26), that the ProMan‑funded remaining capex will give the facility the capability to meet committed demand, and cited an 8–10% long‑term protein market CAGR.
Revenue Growth
Fiscal 2026 revenues of $2.3 million, a nearly sixfold year-over-year increase (≈+400–500%), demonstrating a clear translation of operational progress into sales.
Quarter-over-Quarter Momentum
Double-digit quarter-over-quarter revenue growth in both Q3 and Q4 of fiscal 2026, with management indicating fiscal Q1 (subsequent quarter) is expected to deliver ~50% quarter-over-quarter growth.
Expanding Customer Base and Pipeline
More than 200 active customer projects in the pipeline and 30+ active buyers across the product portfolio, showing breadth and diversification across food applications, brand types and products.
Product Commercialization and Repeat Orders
Commercial production launched for multiple plant-protein products (pea, canola, and FiberPro), with repeat customer orders across the portfolio — a key validation of product quality and adoption.
Production Scaling and Record Performance
Commissioned technology at commercial scale with production improvements; achieved a production performance record of daily production 60% higher than the previous quarter, supporting the ability to meet growing demand.
Quality and Third-Party Validation
Facility audited and certified (BRC) and allergen-free status highlighted — strengthening commercial credibility and reducing customer adoption friction.
Cost Discipline
Management prioritized commercial operations leading to year-over-year reductions in operating expenses: general & administrative down 23% and research & development down 65% in fiscal 2026.
Financing Progress and Partner Support
Announced $6.9 million private placement of convertible notes; $4.0 million closed in fiscal 2026 with the balance closed subsequent to year end. Notable participation by insiders and facility owners underscores partner confidence.
Clear Growth Targets
Management set explicit targets: $10 million in sales in calendar 2026 and achieving positive operating cash flow, providing investors with a concrete near-term objective.

Burcon Nutrascience (BRCNF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BRCNF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 17, 2026
2027 (Q1)
-0.05 / -
-0.191
Jun 24, 2026
2026 (Q4)
-0.07 / -0.21
-0.2411.76% (+0.03)
Feb 11, 2026
2026 (Q3)
0.00 / -0.20
-0.141-40.00% (-0.06)
Nov 12, 2025
2026 (Q2)
-0.04 / -0.20
-0.23415.41% (+0.04)
Aug 13, 2025
2026 (Q1)
-0.05 / -0.19
-0.117-63.64% (-0.07)
Jun 25, 2025
2025 (Q4)
0.00 / -0.24
-0.117-106.06% (-0.12)
Feb 14, 2025
2025 (Q3)
-0.12 / -0.14
-0.23439.58% (+0.09)
Nov 14, 2024
2025 (Q2)
-0.12 / -0.23
-0.117-100.61% (-0.12)
Aug 14, 2024
2025 (Q1)
- / -0.12
-0.23450.15% (+0.12)
Jun 26, 2024
2024 (Q4)
- / -0.12
-0.1170.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BRCNF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jun 24, 2026
$1.62$1.37-15.62%
Feb 11, 2026
$1.33$1.40+5.19%
Nov 12, 2025
$1.62$1.48-8.52%
Aug 13, 2025
$1.99$1.99+0.05%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Burcon Nutrascience (BRCNF) report earnings?
Burcon Nutrascience (BRCNF) is schdueled to report earning on Aug 17, 2026, TBA (Confirmed).
    What is Burcon Nutrascience (BRCNF) earnings time?
    Burcon Nutrascience (BRCNF) earnings time is at Aug 17, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BRCNF EPS forecast?
          BRCNF EPS forecast for the fiscal quarter 2027 (Q1) is -0.05.